Roche Holding stock has delivered a 31.7% return over the past three years, and the current valuation checks suggest the ...

On Tuesday, Roche Holdings AG (OTC:RHHBY) agreed to acquire Poseida Therapeutics, Inc. (NASDAQ:PSTX) for an equity value of approximately $1.5 billion on a fully diluted basis. The deal consideration ...

Check out the latest Roche Holding Ag (RHHVF) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Earlier today, Roche Holdings AG RHHBY announced that it had been made aware of inadvertent disclosure of the second interim analysis of Phase 3 SKYSCRAPER-01 study, evaluating tiragolumab plus ...

Let's start with the background. Currently there are four branded and patent-protected GLP-1 weight-loss drugs on the market. Novo Nordisk owns two of them: Ozempic and Wegovy. Eli Lilly (NYSE: LLY) ...

Roche Holding AG’s experimental lung cancer pill outperformed two approved medicines in a late-stage study, boosting the ...

While Novo Holdings and Catalent continue to voice confidence that their planned $16.5 billion merger will go through before the year is out, the deal has received near-constant criticism over the ...

Roche Holding (SWX:ROP) received FDA priority review for Enspryng (satralizumab) in thyroid eye disease, highlighting a potential at-home treatment option for patients. The company introduced its ...

Roche Holding (OTC: RHHBY) stock jumped 3.4% through 1:05 p.m. ET Monday after the pharmaceutical giant's Genentech subsidiary announced positive phase 3 clinical trial results for its fenebrutinib ...

For the second trading session in less than a week, Roche Holding (OTC: RHHBY) stock really took it on the chin Wednesday. Dispiriting news about its investigational obesity drug was the culprit; ...

Experimental drug, divarasib, showed meaningful improvements in both patients’ overall survival and the time they survived ...